[ Price : $8.95]
FDA grants interchangeable biosimilar status to Celltrions Yuflyma (adalimumab-aaty), a biosimilar copy of AbbVies Humira.[ Price : $8.95]
A presidential executive order tells FDA to suggest administrative and legislative ways to improve the availability of generic and...[ Price : $8.95]
A citizen petition urges FDA to amend the requirements under 21 CFR Part 211 (finished pharmaceuticals GMPs) to mandate the use of...[ Price : $8.95]
A report on the 2024 Global Summit on Regulatory Science calls for a collaborative global effort to harness artificial intelligenc...[ Price : $8.95]
Three FDA staffers discuss the agencys efforts to advance the use of digital health technologies in clinical trials.[ Price : $8.95]
Recent FDA layoffs raise concerns across the drug and biologic industries as experts warn that diminished inspection capacity coul...[ Price : $8.95]
FDA warns Downey, CA-based Naturista Store that it is marketing an unapproved, misbranded drug as a dietary supplement that contai...[ Price : $8.95]
FDA warns Clarence, NY-based PMS4PMS that it is illegally marketing a misbranded over-the-counter menstrual cream that is manufact...